Ultrasound could make the diagnosis of rheumatoid arthritis considerably more accurate, aiding in recommendations for treatment. Treatment decisions can depend on how far the disease has progressed, and the only way to measure the progression of rheumatoid arthritisis to identify which of a patient’s joints show synovitis. Yet a recent study shows that doctors miss swelling in the shoulder joints of 30% of patients.
Ultrasound could make the diagnosis of rheumatoid arthritis considerably more accurate, aiding in recommendations for treatment. Treatment decisions can depend on how far the disease has progressed, and the only way to measure the progression of rheumatoid arthritisis to identify which of a patient's joints show synovitis. Yet a recent study shows that doctors miss swelling in the shoulder joints of 30% of patients.
Rheumatoid arthritis initially presents in small joints such as the fingers and toes, with inflammation and damage spreading to other joints. The presence of extra fluid in the shoulder joint is an indication of disease progression.
Dr. Reijo Luukkainen and colleagues in the rheumatology department at Satakunto Central Hospital in Rauma, Finland, compared ultrasound diagnosis of effusion in shoulder joints of rheumatoid arthritis patients with a doctor's diagnosis of swelling in the same joints. Effusion usually means synovitis in patients with rheumatoid arthritis.
They studied 100 shoulder joints in 50 consecutive patients with rheumatoid arthritis and 40 shoulder joints in 20 healthy controls. The clinical assessments were performed by one doctor and the ultrasound studies by another, both blinded to the other's results. The clinical examination and ultrasound had similar results in 70 of the rheumatoid arthritis patients' shoulder joints. In the remaining 30, ultrasound detected synovitis undetected by clinical exam.
The researchers concluded that ultrasound could considerably improve the accuracy of diagnosis for patients with rheumatoid arthritis.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.